Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 5, 2019Science AdvancesOpen Access

Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics

View Full Paper
Ask AI
Bookmark
Share

Authors

MWMikail WestonEpilepsy Research UKTKTeresa KasererUniversität InnsbruckAWAngela WuUniversity of Michigan

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Weston et al. (2019) studied this question.

synapsesocial.com/papers/6a92ac65de5a63b802a2a20chttps://doi.org/10.1126/sciadv.aaw1567
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The G Protein α Subunit Has a Key Role in Determining the Specificity of Coupling to, but Not the Activation of, G Protein-gated Inwardly Rectifying K+ Channels2000 · 76 citations
  2. 2ChEMBL web services: streamlining access to drug discovery data and utilities2015 · 821 citations
  3. 3Efficient Gene Delivery and Selective Transduction of Glial Cells in the Mammalian Brain by AAV Serotypes Isolated From Nonhuman Primates2009 · 162 citations
  4. 4Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers2017 · 496 citations
  5. 5Comparison of Shape-Matching and Docking as Virtual Screening Tools2006 · 1,034 citations